2024年1月19日 · We compared outcomes of Impella and IABP for LVU during VA‐ECMO. Using the Nationwide Readmissions Database between 2016 and 2020, we analyzed outcomes in 3 groups of patients with cardiogenic shock requiring VA‐ECMO based on LVU strategies: extracorporeal membrane oxygenation (ECMO) only, ECMO with IABP, and ECMO with Impella.

同时这篇文章也用一张简明易懂的图示总结了Impella、IABP、VA-ECMO以及TandemHeart的工作原理和路径差别，非常直观且一目了然。 下面小编就来带您一起看看这篇科学声明究竟有哪些可取之处。

2024年1月12日 · 1. ECPella (venoarterial extracorporeal membrane oxygenation [VA-ECMO] with an Impella for LV decompression)， 2. VA-ECMO with an intra-aortic balloon pump (IABP), 3. BiPella (left-sided support with an Impella 2.5/CP/5.5 and right-sided support with an Impella RP), 4. right-sided TandemHeart with an LV Impella. ICU患者管理要点

2023年12月1日 · In patients with cardiogenic shock, IABP may be as effective as Impella in LV unloading. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) use for circulatory support in cardiogenic shock results in increased left ventricular (LV) afterload.

2022年12月15日 · We aimed to compare postapproval outcomes and costs of Impella versus IABP support for high-risk PCI in real-world practice across hospitals in the United States. We identified patients from the Premier Healthcare Database undergoing nonemergent Impella- or IABP-supported high-risk PCI.

2021年12月1日 · We compared hospitalizations for age, gender, comorbidities, use of vasopressor support, and outcomes between patients who received IABP vs. Impella during the hospitalization. The Elixhauser Comorbidity Index was used to identify comorbid disorders.

2023年10月7日 · The use of concomitant Impella or intra-aortic balloon pump (IABP) have been proposed as adjunct devices for LV unloading. The authors sought to compare head-to-head efficacy and safety outcomes between the 2 LV unloading strategies.

2025年2月3日 · To the best of our knowledge, this nationwide cohort study had the largest number of patients among the studies comparing a percutaneous ventricular assist device (Impella) versus intra‐aortic balloon pump (IABP) in combination with venoarterial extracorporeal membrane oxygenation (ECMO) (ECPella versus ECMO+IABP).

Short-term percutaneous circulatory support devices provide superior hemodynamic support compared with the intra-aortic balloon pump (IABP). American guidelines have downgraded the recommendation for usage of the IABP from Class I to IIa, and European guidelines to Class III.

We investigated the benefit of Impella, a modern percutaneous mechanical support (pMCS) device, versus former standard intra-aortic balloon pump (IABP) in acute myocardial infarction complicated by cardiogenic shock (AMICS). This single-centre, retrospective study included patients with AMICS receiving pMCS with either Impella or IABP.